Benbrahim N, Dubé C, Vallieres S, Gascon-Barré M
Centre de Recherche Clinique André-Viallet, Hôpital Saint-Luc, Montreal, Quebec, Canada.
Biochem J. 1988 Oct 1;255(1):91-7. doi: 10.1042/bj2550091.
The role played by 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and/or by calcium on the C-25 hydroxylation of vitamin D3 (D3) was studied in hepatocytes isolated from D-depleted rats which were divided into four treatment groups: Group 1 served as controls, Group 2 received calcium gluconate, Groups 3 and 4 were infused with 1,25(OH)2D3 at 7 and 65 pmol/24 h x 7 days respectively. The treatments normalized serum calcium in all but the controls which remained hypocalcaemic, while serum 1,25(OH)2D3 remained low in Groups 1 and 2 but increased to physiologic and supraphysiologic levels in Groups 3 and 4. The data show that basal D3-25 hydroxylase activities were not significantly affected by any of the treatments. Addition of CaCl2, EGTA, or Quin-2 in vitro revealed that relative to basal values, EGTA strongly inhibited the enzyme activity in all groups (P less than 0.0001), except in G 1; Quin-2 and CaCl2 had no significant effect on the activity of the enzyme in any of the groups. Addition of 1,25(OH)2D3 or A23187 in vitro in the presence of CaCl2 revealed that 1,25(OH)2D3 did not significantly affect enzyme activity, while A23187 was found to stimulate its activity in vitamin D-depleted animals, but most specifically in Group 2 (P less than 0.001); low serum calcium (Group 1) dampened (P less than 0.01), and 1,25(OH)2D3 treatment in vivo totally blunted (P less than 0.001) the response to A23187. The data suggest that 1,25(OH)2D3 supplementation in vivo has per se little or no effect on the basal D3-25 hydroxylase activity. The data show, however, that the magnitude of the response to various challenges in vitro is greatly influenced by the conditioning in vivo of the animals. They also show that A23187 can be a potent stimulator of the enzyme activity, which allowed us to demonstrate a significant reserve for the C-25 hydroxylation of D3 which is well expressed in hepatocytes obtained from D-depleted calcium-supplemented rats.
研究了1,25 - 二羟基维生素D3 [1,25(OH)2D3]和/或钙对维生素D3(D3)C - 25羟化作用的影响。实验选用从维生素D缺乏大鼠分离的肝细胞,将其分为四个处理组:第1组作为对照组,第2组给予葡萄糖酸钙,第3组和第4组分别以7和65 pmol/24 h×7天的剂量输注1,25(OH)2D3。除对照组仍处于低钙血症外,其他处理均使血清钙恢复正常;第1组和第2组血清1,25(OH)2D3仍较低,而第3组和第4组则升高至生理和超生理水平。数据显示,基础D3 - 25羟化酶活性不受任何处理的显著影响。体外添加氯化钙、乙二醇双(2 - 氨基乙基醚)四乙酸(EGTA)或喹啉 - 2后发现,与基础值相比,EGTA强烈抑制所有组的酶活性(P < 0.0001),第1组除外;喹啉 - 2和氯化钙对任何组的酶活性均无显著影响。在氯化钙存在下体外添加1,25(OH)2D3或离子载体A23187发现,1,25(OH)2D3对酶活性无显著影响,而A23187可刺激维生素D缺乏动物的酶活性,尤其是第2组(P < 0.001);低血清钙(第1组)减弱了这种反应(P < 0.01),体内1,25(OH)2D3处理则完全消除了对A23187的反应(P < 0.001)。数据表明,体内补充1,25(OH)2D3本身对基础D3 - 25羟化酶活性几乎没有影响。然而,数据显示,体外对各种刺激的反应程度受动物体内预处理的极大影响。数据还表明,A23187可以是酶活性的有效刺激剂,这使我们能够证明在从维生素D缺乏且补充钙的大鼠获得的肝细胞中,D3的C - 25羟化有显著的储备能力。